Robert Connelly

Robert Connelly

President, Chief Executive Officer, and DirectoratElicio Therapeutics· In proxies 2022–2025

Pay in FY2025-7% from the year before · Elicio Therapeutics stock +56.1% the same year

Robert Connelly was paid $1.9M in FY2025 (Dec), down 7%. Elicio Therapeutics stock rose 56.1% that year.

Pay$100 in the stock at the end of FY21 → $27
Pay is from the Summary Compensation Table of each Elicio Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Elicio TherapeuticsPublic company · 4 yr
    • President, Chief Executive Officer, and Director2022 – Present · 4 yrStock in role -93%
  2. Axcella Health Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Anchiano Therapeutics Ltd.Public company · 1 yr
    • Director2018 – 2019 · 1 yrNo stock prices for these years
  4. Kaleido Biosciences, Inc.Public company · 3 yr
    • Director2015 – 2018 · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?